MoonLake Immunotherapeutics

MLTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$12.87

+$0.32 (+2.55%)

Sep 22, 2026, 12:09 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-229.1M	-121.24M	-44.08M	-49.97M	-53.64M	-90.84K
Depreciation & Amortization	2.62M	1.38M	13.16K	12.36K	4.97K	n/a
Stock-Based Compensation	12.9M	7.28M	7.11M	9.65M	10.86M	n/a
Other Working Capital	21.9M	-2M	-6.22M	-44.8K	3.06M	-215.94K
Other Non-Cash Items	-2.3M	-225.71K	399.51K	-4.51M	13.98M	-9.92K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	19.88M	-3.78M	-6.22M	-1.43M	4.48M	-215.94K
Operating Cash Flow	-196.01M	-116.59M	-42.78M	-55.89M	-35.18M	-316.69K
Capital Expenditures	-35K	-519.52K	-284.63K	-16.01K	-50.71K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-265.37M	-350.28M	-175.73M	-42.23M	n/a	-115M
Sales Maturities Of Investments	468.4M	145.2M	150.83M	9.9M	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	202.99M	-205.6M	-25.18M	-32.34M	-50.71K	-115M
Debt Repayment	73.02M	n/a	n/a	-15M	15M	n/a
Common Stock Repurchased	n/a	-50	n/a	n/a	-6.2K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	-1.23M	-2.75M	134.69M	n/a	-347.38K
Financial Cash Flow	146M	51.31M	479.7M	119.69M	43.26M	116.65M
Net Cash Flow	154.09M	-270.74M	411.66M	31.47M	6.7M	1.34M
Free Cash Flow	-196.04M	-117.11M	-43.06M	-55.91M	-35.23M	-316.69K
Adj. Free Cash Flow	-208.94M	-124.39M	-50.17M	-65.56M	-46.09M	-316.69K
Maintenance CapEx	-35K	-519.52K	-13.16K	-12.36K	-4.97K	n/a
Growth CapEx	n/a	n/a	-271.48K	-3.65K	-45.74K	n/a
Owner Earnings	-196.04M	-117.11M	-42.79M	-55.91M	-35.18M	-316.69K